CONTEXT: Persistent pain after treatment for breast cancer (PPBCT) is a common side effect of breast cancer treatment, with prevalence as high as 50%. It is predominantly a neuropathic condition. OBJECTIVES: The aim of this cross-sectional, questionnaire-based study was to examine the emotional characteristics of patients with PPBCT in long-term breast cancer patients. A secondary objective was to characterize the risk factors and severity of that pain. METHODS: From March 1, 2010 to April 9, 2010, long-term follow-up patients were invited to complete a questionnaire. This recorded their surgical and demographic data and ascertained whether they had PPBCT. If the patient had pain, she completed a range of validated self-report questionnaires and questions about the nature of the pain, including a visual analogue scale. RESULTS: One hundred eleven patients completed the questionnaire; 33 (29.7%) patients reported chronic pain at a median time of 64 months postoperatively (interquartile range 54.25). Patients with persistent pain were not significantly more anxious (t(105)=-0.369, P=0.713) or depressed (t(105)=0.713, P=0.507) than patients without pain. Patients with constant pain compared with intermittent pain were significantly more anxious (t(25)=-3.460, P=0.002). Preoperative pain conferred a fivefold increased risk of PPBCT (odds ratio [OR]=5.17, 95% confidence interval [CI]=1.79-14.97, P=0.002); chemotherapy conferred a threefold increased risk (OR=3.004, 95% CI=1.22-7.40, P=0.017). CONCLUSION: We have shown significant numbers of patients suffer from PPBCT. At a median time of 64.5 months, women with pain are not significantly more anxious or depressed than women without pain. Preoperative pain and chemotherapy have been highlighted as risk factors.
CONTEXT: Persistent pain after treatment for breast cancer (PPBCT) is a common side effect of breast cancer treatment, with prevalence as high as 50%. It is predominantly a neuropathic condition. OBJECTIVES: The aim of this cross-sectional, questionnaire-based study was to examine the emotional characteristics of patients with PPBCT in long-term breast cancerpatients. A secondary objective was to characterize the risk factors and severity of that pain. METHODS: From March 1, 2010 to April 9, 2010, long-term follow-up patients were invited to complete a questionnaire. This recorded their surgical and demographic data and ascertained whether they had PPBCT. If the patient had pain, she completed a range of validated self-report questionnaires and questions about the nature of the pain, including a visual analogue scale. RESULTS: One hundred eleven patients completed the questionnaire; 33 (29.7%) patients reported chronic pain at a median time of 64 months postoperatively (interquartile range 54.25). Patients with persistent pain were not significantly more anxious (t(105)=-0.369, P=0.713) or depressed (t(105)=0.713, P=0.507) than patients without pain. Patients with constant pain compared with intermittent pain were significantly more anxious (t(25)=-3.460, P=0.002). Preoperative pain conferred a fivefold increased risk of PPBCT (odds ratio [OR]=5.17, 95% confidence interval [CI]=1.79-14.97, P=0.002); chemotherapy conferred a threefold increased risk (OR=3.004, 95% CI=1.22-7.40, P=0.017). CONCLUSION: We have shown significant numbers of patients suffer from PPBCT. At a median time of 64.5 months, women with pain are not significantly more anxious or depressed than women without pain. Preoperative pain and chemotherapy have been highlighted as risk factors.
Authors: Sara N Edmond; Rebecca A Shelby; Francis J Keefe; Hannah M Fisher; John E Schmidt; Mary S Soo; Celette S Skinner; Gretchen M Ahrendt; Jessica Manculich; Jules H Sumkin; Margarita L Zuley; Dana H Bovbjerg Journal: Clin J Pain Date: 2017-01 Impact factor: 3.442
Authors: Spenser Hughes; Lisa M Jaremka; Catherine M Alfano; Ronald Glaser; Stephen P Povoski; Adele M Lipari; Doreen M Agnese; William B Farrar; Lisa D Yee; William E Carson; William B Malarkey; Janice K Kiecolt-Glaser Journal: Psychoneuroendocrinology Date: 2014-01-05 Impact factor: 4.905
Authors: Ellen M Lavoie Smith; Celia M Bridges; Grace Kanzawa; Robert Knoerl; James P Kelly; Anna Berezovsky; Charis Woo Journal: Curr Pain Headache Rep Date: 2014-11
Authors: Megan E Renna; M Rosie Shrout; Annelise A Madison; Maryam Lustberg; Stephen P Povoski; Doreen M Agnese; Raquel E Reinbolt; Robert Wesolowski; Nicole O Williams; Bhuvaneswari Ramaswamy; Sagar D Sardesai; Anne M Noonan; Jeffrey B VanDeusen; Daniel G Stover; Mathew Cherian; William B Malarkey; Michael Di Gregorio; Janice K Kiecolt-Glaser Journal: Int J Behav Med Date: 2022-07-13
Authors: Sy-Huey Doong; Anand Dhruva; Laura B Dunn; Claudia West; Steven M Paul; Bruce A Cooper; Charles Elboim; Gary Abrams; John D Merriman; Dale J Langford; Heather Leutwyler; Christina Baggott; Kord Kober; Bradley E Aouizerat; Christine Miaskowski Journal: Biol Res Nurs Date: 2014-10-10 Impact factor: 2.522
Authors: Robin J Bell; Penelope J Robinson; Fathima Nazeem; Mary Panjari; Pamela Fradkin; Max Schwarz; Susan R Davis Journal: J Cancer Surviv Date: 2013-08-23 Impact factor: 4.442
Authors: Megan E Renna; M Rosie Shrout; Annelise A Madison; Maryam Lustberg; Stephen P Povoski; Doreen M Agnese; Raquel E Reinbolt; Robert Wesolowski; Nicole O Williams; Bhuvaneswari Ramaswamy; Sagar D Sardesai; Anne M Noonan; Jeffrey B VanDeusen; William B Malarkey; Janice K Kiecolt-Glaser Journal: J Behav Med Date: 2020-11-01
Authors: Janine T Hidding; Carien H G Beurskens; Philip J van der Wees; Hanneke W M van Laarhoven; Maria W G Nijhuis-van der Sanden Journal: PLoS One Date: 2014-05-09 Impact factor: 3.240
Authors: Lynn V Doering; Belinda Chen; Anthony McGuire; Rebecca Cross Bodán; Michael R Irwin Journal: Psychosom Med Date: 2014 Jul-Aug Impact factor: 4.312
Authors: M T Fallon; D J Storey; A Krishan; C J Weir; R Mitchell; S M Fleetwood-Walker; A C Scott; L A Colvin Journal: Support Care Cancer Date: 2015-02-15 Impact factor: 3.603